The latest announcement is out from Mcpherson’S Limited ( (AU:MCP) ).
McPherson’s Limited reported a decline in sales revenue by 7.6% to $70.7 million for the half-year ended December 31, 2024, compared to the previous period. The company also experienced a loss from continuing operations both before and after tax, indicating financial challenges. The absence of an interim dividend further highlights the company’s current financial strain, impacting shareholder returns.
More about Mcpherson’S Limited
McPherson’s Limited is a supplier of essential health, beauty, and wellness products in Australia, known for its five core household brands: Manicare, Lady Jayne, Dr LeWinns, Swisspers, and Fusion Health. The company focuses on growing these brands through pharmacy, grocery, and e-commerce channels, and also offers products in haircare, vitamins, supplements, fragrance, and nutrition. Headquartered in Sydney, McPherson’s operates offices in Melbourne, Auckland, Hong Kong, and Shanghai, and is listed on the Australian Securities Exchange.
YTD Price Performance: 1.13%
Average Trading Volume: 1,700
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €27.49M
See more data about MCP stock on TipRanks’ Stock Analysis page.